National and Kapodistrian University of Athens
Εκτίμηση ευερεθιστότητας, άγχους, κατάθλιψης και ποιότητα ζωής σε καπνιστές κατά τη θεραπεία διακοπής καπνίσματος
Abstract
dc:descriptionIntroduction: Stopping smoking habit is undoubtedly a tedious, particularly demanding and stressful process for the smoker. The existing knowledge and experience confirms the existence and impact of changes in both the mood and psychology of smokers during the cessation process.Purpose: The purpose of this study is to assess the irritability, depression, anxiety and health related quality of life in patients attending smoking cessation clinic.Material and Methods: 94 smokers took part in this study (response rate: 85.45%), who attended voluntarily the clinic of quitting smoke of a tertiary hospital with the will to quit smoking and completed a questionnaire in four different phases of the study, baseline (phase 0), 1 month later (stage 1), 3 months (phase 2) and 12 months (phase 3) from initial visit. Apart from demographic and smoking habits they completed the EuroQol (EQ-5D), that is a reliable and valid tool for determining quality of life, Fagerström scale, which determines the degree of nicotine dependence and irritability scale Snaith-IDA (Irritability Depression Anxiety) for assessing irritability and anxiety symptoms. The statistical data processing was done with the statistical package SPSS 19.Results: Smokers with a mean age of 55 years and an average age of starting smoking 20 years consumed 25 cigarettes per day. A percentage of 72.2% said they had previously tried to quit smoking, identified the importance quitting at 8.34 and the difficulty at 8.58 in a ten-point scale. At the end of the study 41.2% of the sample had managed to quit smoking. The 36.2% of the sample is determined as much dependent according to Fagerström scale. Irritability (inward-outward) anxiety and depression reached its upper limit during the Phase 1 of the study that is the first month of treatment of smoking cessation and stress is almost at the same levels as it was at the phase of inclusion in the survey and in phase of integration. With regard to the participants that eventually stopped smoking comparing phase 1 and phase 3 a statistically significant correlation of EQ-D5 VAS between phase the phases was found, with the mean level to rise from 65.12 to 74.35 and a p-value 0.000. Conclusions: Individuals who are in a smoking cessation treatment process experience elevated stress levels, internal irritability and depression irrespective of gender and age. Individuals, who finally manage to stop smoking, evaluate their quality of life higher in EQD-5. Therefore, the support of people in smoking cessation process is particularly important in order to cope with the irritability, anxiety and depression they experience.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Hatzilia, Despoina
- Χατζηλία, Δέσποινα
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41154